VIDAS TESTOSTERONE (TES), MODEL 30 418— 510(k) K021326

Clearance details

Applicant

bioMerieux, Inc.

Product code

Code CDZ

Device class

Class 1

Regulation

21 CFR 862.1680

Advisory panel

Clinical Chemistry

Date received

2002-04-26

Decision date

2002-07-18

Decision

Substantially Equivalent

Clearance type

Traditional

Location

Hazelwood, MO, US

• K252728 — IDS-iSYS Total Testosterone2026-04-15
• K240865 — IDS-iSYS Free Testosterone2024-10-23
• K233480 — Access SHBG2024-02-08
• K223405 — Access Testosterone2023-01-13
• K211685 — Elecsys Testosterone II2022-05-06

• K260160 — VITEK REVEAL GN AST Assay and VITEK REVEAL AST System2026-07-08
• K260282 — VITEK 2 AST-Streptococcus Inducible Clindamycin Resistance2026-04-15
• K251579 — VITEK 2 AST-Gram Negative Cefazolin (=<1-=>32 µg/mL)2025-08-21
• K234012 — VITEK COMPACT PRO2025-03-14
• K232967 — VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)2024-06-12

• Z-2339-2017 — VIDAS Testosterone, Ref 30418Class II·Terminated·bioMerieux, Inc.·20170515

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K021326.